Prior Authorization During Surgery Is Not Oversight

Key Takeaways

• Insurers can modify surgeries during the operation
• Surgeons often obey without patient or family input
• Prior‑authorization adds $260 B in yearly admin costs
• Consent forms don’t guarantee unchanged procedures under anesthesia

Pulse Analysis

Prior‑authorization was originally designed as a safeguard against unnecessary procedures, but over the past decade it has morphed into a real‑time gatekeeping tool. Insurers now staff call centers that can reach operating rooms the moment a surgeon begins an incision, demanding changes that have little clinical justification. The American Medical Association reports that 93 percent of physicians see delays or alterations caused by these calls, contributing to an estimated $260 billion in administrative overhead each year. This shift places paperwork above patient care, eroding trust in the health‑care system.

Recent high‑profile incidents underscore the human cost of this trend. In one case, a post‑menopausal woman undergoing a laparoscopic‑assisted hysterectomy was instructed by an insurance representative to leave an ovary in place, despite no medical benefit and increased cancer risk. In another, a breast‑reconstruction surgeon was pulled from the operating table by UnitedHealthcare to answer questions about overnight stay requirements, despite the patient being under anesthesia with a known cancer diagnosis. Both surgeons complied, highlighting how insurer directives can override clinical judgment, expose patients to avoidable complications, and create legal gray areas around consent.

The industry response has been mixed. Some hospital systems are instituting written policies that prohibit intra‑operative changes without direct surgeon approval, while others continue to defer to insurers to avoid network penalties. Advocacy groups are calling for federal legislation that limits real‑time prior‑authorization to pre‑operative review, preserving surgeon autonomy and patient safety. For patients, proactive steps—such as confirming the exact scope of authorization, designating a medical advocate, and demanding written guarantees—can provide a buffer against unexpected intra‑operative alterations. Ultimately, aligning financial oversight with clinical decision‑making is essential to curb wasteful spending and protect patient outcomes.